Roles of circRNAs in regulating the tumor microenvironment

Tao Liu1, Kaijun Long1, Zhengfeng Zhu1

  • 1Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Zunyi, 563000, Guizhou, China.

Insights

Circular RNAs (circRNAs) are key regulators in the tumor microenvironment (TME), influencing cancer growth and metastasis. This review explores their roles in angiogenesis, matrix remodeling, and immunosuppression, highlighting TME modulation for cancer therapy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Circular RNAs (circRNAs) are prevalent non-coding RNAs with largely unexplored functions in eukaryotic cells.
  • While known circRNAs act as microRNA sponges, bind RNA-binding proteins, or function as transcription factors, their roles in cancer are expanding.
  • Tumor growth is complex, influenced by the tumor microenvironment (TME) beyond genetic mutations.

Purpose of the Study:

  • To review the multifaceted roles of circRNAs within the TME.
  • To elucidate how circRNAs regulate key aspects of tumor progression, including angiogenesis, matrix remodeling, and immunosuppression.
  • To discuss the influence of hypoxia and commensal microorganisms on circRNA production and their impact on the TME.

Main Methods:

  • Literature review of current research on circRNAs in cancer.
  • Analysis of circRNA regulatory mechanisms (e.g., miRNA sponges, protein binding).
  • Examination of circRNA involvement in TME components and processes.

Main Results:

  • CircRNAs significantly regulate angiogenesis, matrix remodeling, and immunosuppression within the TME.
  • Hypoxia and commensal microorganisms are identified as modulators of circRNA production, impacting tumor growth.
  • circRNAs are implicated in tumor growth and metastasis through TME regulation.

Conclusions:

  • Modulating the TME via circRNAs presents a promising therapeutic strategy for cancer.
  • Further research into circRNA functions and their interactions within the TME is crucial for developing novel cancer treatments.
  • Understanding circRNA dynamics offers insights into tumor progression and potential intervention points.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K